Search

Search Constraints

You searched for: Author/Creator Tsaur, Igor

Search Results

1. A real‐world comparison of docetaxel versus abiraterone acetate for metastatic hormone‐sensitive prostate cancer. (10th August 2021)

2. Aggressive variants of prostate cancer – Are we ready to apply specific treatment right now?. (May 2019)

3. Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review. (March 2022)

4. Cross‐communication between histone H3 and H4 acetylation and Akt‐mTOR signalling in prostate cancer cells. Issue 7 (30th April 2014)

5. CT-guided nephrostomy–An expedient tool for complex clinical scenarios. Issue 110 (January 2019)

6. Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidence. Issue 1 (January 2022)

7. Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidence. Issue 1 (January 2022)

9. How can we expand active surveillance criteria in patients with low‐ and intermediate‐risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator. (3rd June 2018)

10. Incidence, Risk Factors and Management of Symptomatic Lymphoceles after Radical Retropubic Prostatectomy. Issue 6 (November 2017)